Cytiva News

1. Cytiva Opens Cell Culture Center Of Excellence In Massachusetts 11/9/2022

   Global life sciences leader Cytiva opened a new Cell Culture Center of Excellence at its Marlborough, Massachusetts location.

2. Cytiva Strengthens Cell Line Development With CEVEC Acquisition 10/6/2022

   Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cell line development and viral vector manufacturing technologies. CEVEC will further strengthen Cytiva's leading position in biomanufacturing solutions.

3. Cytiva Expanding US Operations 7/13/2022

   The new chromatography resins manufacturing site is part of Cytiva and Pall Corporation’s 1.5 billion USD capacity expansion investment.

4. Cytiva Attains Business Continuity Management System ISO Certification 1/11/2022

   The new ISO 22301:2019 certification covers methods and procedures for maintaining emergency response, crisis management, and business continuity capabilities, including communication, implementation, and continual improvement.

5. Cytiva Acquires GoSilico To Strengthen Digital Capabilities In Bioprocessing 6/2/2021

   Global life sciences leader Cytiva has acquired the German scientific software maker GoSilico, in a move that will differentiate Cytiva as a premier partner in bioprocessing.

6. Cytiva Delivers KUBio To Lonza 1/14/2021

   Cytiva, a global life sciences leader, has successfully completed another KUBio installation, this time to global healthcare solutions provider Lonza, in Guangzhou Biopark, China.

7. Cytiva's Fibro PrismA Technology Accelerates mAb Purification In LifeArc's Covid-19 Research 10/8/2020

   Cytiva, a global life sciences leader, made Fibro PrismA, the first product based on its new protein A fiber chromatography technology, available commercially earlier this year. The new technology is already accelerating research for customers and collaborators, such as LifeArc.

8. New KUBio Box For Viral Vectors Boosts Gene Therapy Manufacturing 10/28/2019

   GE Healthcare Life Sciences is launching KUBio™ box, a fully-integrated, flexible, and adaptable biomanufacturing environment to accelerate the production of viral vector-based gene therapies. The latest addition to the KUBio modular bioprocessing portfolio, KUBio box is expected to speed gene therapies to market and contribute to increased capacity in the viral vector area.

9. Lonza To Establish Strategic Biomanufacturing Base In China Using GE Healthcare Solution 12/10/2018

   Lonza recently announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (CN).

10. Rentschler Biotechnologie Expands European Manufacturing Capabilities With GE Healthcare Life Sciences Bioprocess Technologies 4/14/2015

    GE Healthcare Life Sciences a provider of tools, technologies and services to the biopharmaceutical manufacturing industry and Rentschler Biotechnologie GmbH, a leading contract manufacturing and development organization (CDMO) for biopharmaceuticals, announced recently a joint celebration to mark the handover of GE Healthcare’s 1000th ÄKTAprocess and the expansion of Rentschler’s biopharmaceutical manufacturing capabilities in Laupheim, Germany.